Moreover, the functions of CDK1/cyclin B1 in human cancer had not been properly elucidated similar to CDK4/CDK6/cyclin D. Multi-CDK inhibitors that target CDK1 are well-tolerated in cancer patients (Byrd et al., 2007; Tibes et al., 2008). The gene discussed is CCNB1; the disease is cancer.